Abstract
Our DNA is continuously assaulted from a plethora of sides including exogenous environmental sources (for examples ionizing radiation (IR) or exposure to environmental genotoxic compounds) and endogenous sources such as replication fork collapse during regular DNA replication, during normal DNA repair events and immunoglobulin V(D)J gene rearrangement. However the incorrect repair of DNA breaks results in significant genomic instability due to gross chromosomal loss, amplification, or rearrangements that can lead to cancer. In healthy cells, these harmful effects are controlled by large, multi-component protein complexes, beginning with the detection of DNA damage and the induction of complex protein signalling cascades that ensure genomic integrity. These signalling cascades promote cell cycle arrest, allowing the cell sufficient time to evaluate and where possible to repair the DNA damage. In the presence of sustained damage or when this damage cannot be repaired, the cell can instigate an apoptotic response (programmed cell death) to ensure that the damaged DNA is not passed to daughter cells, thus preserving genome integrity. In cancer, these processes are subverted, deregulated and inactivated. Over the course of this chapter the processes, key proteins and pathways involved in the cell cycle, DNA repair and apoptosis will be reviewed with particular focus on disease, in particular cancer and how these components could be therapeutically targeted.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gopinathan L, Ratnacaram CK, Kaldis P (2011) Established and novel Cdk/cyclin complexes regulating the cell cycle and development. Results Probl Cell Differ 53:365–389
Valerie K, Povirk LF (2003) Regulation and mechanisms of mammalian double-strand break repair. Oncogene 22:5792–5812
Khanna KK, Jackson SP (2001) DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet 27:247–254
van Gent DC, Hoeijmakers JH, Kanaar R (2001) Chromosomal stability and the DNA double-stranded break connection. Nat Rev Genet 2:196–206
Chen S, Inamdar KV, Pfeiffer P, Feldmann E, Hannah MF, Yu Y, Lee JW, Zhou T, Lees-Miller SP, Povirk LF (2001) Accurate in vitro end joining of a DNA double strand break with partially cohesive 3′-overhangs and 3′-phosphoglycolate termini: effect of Ku on repair fidelity. J Biol Chem 276:24323–24330
Batzer MA, Deininger PL (2002) Alu repeats and human genomic diversity. Nat Rev Genet 3:370–379
Takata M, Sasaki MS, Sonoda E, Morrison C, Hashimoto M, Utsumi H, Yamaguchi-Iwai Y, Shinohara A, Takeda S (1998) Homologous recombination and non-homologous end-joining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells. EMBO J 17:5497–5508
Essers J, van Steeg H, de Wit J, Swagemakers SM, Vermeij M, Hoeijmakers JH, Kanaar R (2000) Homologous and non-homologous recombination differentially affect DNA damage repair in mice. EMBO J 19:1703–1710
Critchlow SE, Jackson SP (1998) DNA end-joining: from yeast to man. Trends Biochem Sci 23:394–398
Smith GC, Jackson SP (1999) The DNA-dependent protein kinase. Genes Dev 13:916–934
Yoo S, Dynan WS (1999) Geometry of a complex formed by double strand break repair proteins at a single DNA end: recruitment of DNA-PKcs induces inward translocation of Ku protein. Nucleic Acids Res 27:4679–4686
Hammarsten O, Chu G (1998) DNA-dependent protein kinase: DNA binding and activation in the absence of Ku. Proc Natl Acad Sci U S A 95:525–530
Singleton BK, Torres-Arzayus MI, Rottinghaus ST, Taccioli GE, Jeggo PA (1999) The C terminus of Ku80 activates the DNA-dependent protein kinase catalytic subunit. Mol Cell Biol 19:3267–3277
Gell D, Jackson SP (1999) Mapping of protein-protein interactions within the DNA-dependent protein kinase complex. Nucleic Acids Res 27:3494–3502
DeFazio LG, Stansel RM, Griffith JD, Chu G (2002) Synapsis of DNA ends by DNA-dependent protein kinase. EMBO J 21:3192–3200
Cary RB, Peterson SR, Wang J, Bear DG, Bradbury EM, Chen DJ (1997) DNA looping by Ku and the DNA-dependent protein kinase. Proc Natl Acad Sci U S A 94:4267–4272
Calsou P, Delteil C, Frit P, Drouet J, Salles B (2003) Coordinated assembly of Ku and p460 subunits of the DNA-dependent protein kinase on DNA ends is necessary for XRCC4-ligase IV recruitment. J Mol Biol 326:93–103
Hsu HL, Yannone SM, Chen DJ (2002) Defining interactions between DNA-PK and ligase IV/XRCC4. DNA Repair (Amst) 1:225–235
Lee JW, Yannone SM, Chen DJ, Povirk LF (2003) Requirement for XRCC4 and DNA ligase IV in alignment-based gap filling for nonhomologous DNA end joining in vitro. Cancer Res 63:22–24
Modesti M, Hesse JE, Gellert M (1999) DNA binding of Xrcc4 protein is associated with V(D)J recombination but not with stimulation of DNA ligase IV activity. EMBO J 18:2008–2018
Nick McElhinny SA, Snowden CM, McCarville J, Ramsden DA (2000) Ku recruits the XRCC4-ligase IV complex to DNA ends. Mol Cell Biol 20:2996–3003
Mahajan KN, Nick McElhinny SA, Mitchell BS, Ramsden DA (2002) Association of DNA polymerase mu (pol mu) with Ku and ligase IV: role for pol mu in end-joining double-strand break repair. Mol Cell Biol 22:5194–5202
Matsumoto Y, Suzuki N, Namba N, Umeda N, Ma XJ, Morita A, Tomita M, Enomoto A, Serizawa S, Hirano K et al (2000) Cleavage and phosphorylation of XRCC4 protein induced by X-irradiation. FEBS Lett 478:67–71
Leber R, Wise TW, Mizuta R, Meek K (1998) The XRCC4 gene product is a target for and interacts with the DNA-dependent protein kinase. J Biol Chem 273:1794–1801
Grawunder U, Wilm M, Wu X, Kulesza P, Wilson TE, Mann M, Lieber MR (1997) Activity of DNA ligase IV stimulated by complex formation with XRCC4 protein in mammalian cells. Nature 388:492–495
Yannone SM, Roy S, Chan DW, Murphy MB, Huang S, Campisi J, Chen DJ (2001) Werner syndrome protein is regulated and phosphorylated by DNA-dependent protein kinase. J Biol Chem 276:38242–38248
Yannone SM, Khan IS, Zhou RZ, Zhou T, Valerie K, Povirk LF (2008) Coordinate 5′ and 3′ endonucleolytic trimming of terminally blocked blunt DNA double-strand break ends by Artemis nuclease and DNA-dependent protein kinase. Nucleic Acids Res 36:3354–3365
Ma Y, Pannicke U, Schwarz K, Lieber MR (2002) Hairpin opening and overhang processing by an Artemis/DNA-dependent protein kinase complex in nonhomologous end joining and V(D)J recombination. Cell 108:781–794
Niewolik D, Pannicke U, Lu H, Ma Y, Wang LC, Kulesza P, Zandi E, Lieber MR, Schwarz K (2006) DNA-PKcs dependence of Artemis endonucleolytic activity, differences between hairpins and 5′ or 3′ overhangs. J Biol Chem 281:33900–33909
Weterings E, Verkaik NS, Keijzers G, Florea BI, Wang SY, Ortega LG, Uematsu N, Chen DJ, van Gent DC (2009) The Ku80 carboxy terminus stimulates joining and artemis-mediated processing of DNA ends. Mol Cell Biol 29:1134–1142
Smith GR (2004) How homologous recombination is initiated: unexpected evidence for single-strand nicks from v(d)j site-specific recombination. Cell 117:146–148
Jung D, Alt FW (2004) Unraveling V(D)J recombination; insights into gene regulation. Cell 116:299–311
Bogue MA, Jhappan C, Roth DB (1998) Analysis of variable (diversity) joining recombination in DNAdependent protein kinase (DNA-PK)-deficient mice reveals DNA-PK-independent pathways for both signal and coding joint formation. Proc Natl Acad Sci U S A 95:15559–15564
Gilley D, Tanaka H, Hande MP, Kurimasa A, Li GC, Oshimura M, Chen DJ (2001) DNA-PKcs is critical for telomere capping. Proc Natl Acad Sci U S A 98:15084–15088
Samper E, Goytisolo FA, Slijepcevic P, van Buul PP, Blasco MA (2000) Mammalian Ku86 protein prevents telomeric fusions independently of the length of TTAGGG repeats and the G-strand overhang. EMBO Rep 1:244–252
Goytisolo FA, Samper E, Edmonson S, Taccioli GE, Blasco MA (2001) The absence of the dna-dependent protein kinase catalytic subunit in mice results in anaphase bridges and in increased telomeric fusions with normal telomere length and G-strand overhang. Mol Cell Biol 21:3642–3651
d’Adda di Fagagna F, Tong WM, Roth D, Lansdorp PM, Wang ZQ, Jackson SP (2001) Effects of DNA nonhomologous end-joining factors on telomere length and chromosomal stability in mammalian cells. Curr Biol 11:1192–1196
Bailey SM, Meyne J, Chen DJ, Kurimasa A, Li GC, Lehnert BE, Goodwin EH (1999) DNA double-strand break repair proteins are required to cap the ends of mammalian chromosomes. Proc Natl Acad Sci U S A 96:14899–14904
Boulton SJ, Jackson SP (1998) Components of the Ku-dependent non-homologous end-joining pathway are involved in telomeric length maintenance and telomeric silencing. EMBO J 17:1819–1828
Gravel S, Larrivee M, Labrecque P, Wellinger RJ (1998) Yeast Ku as a regulator of chromosomal DNA end structure. Science 280:741–744
Hsu HL, Gilley D, Blackburn EH, Chen DJ (1999) Ku is associated with the telomere in mammals. Proc Natl Acad Sci U S A 96:12454–12458
Bianchi A, de Lange T (1999) Ku binds telomeric DNA in vitro. J Biol Chem 274:21223–21227
Hsu HL, Gilley D, Galande SA, Hande MP, Allen B, Kim SH, Li GC, Campisi J, Kohwi-Shigematsu T, Chen DJ (2000) Ku acts in a unique way at the mammalian telomere to prevent end joining. Genes Dev 14:2807–2812
Espejel S, Franco S, Sgura A, Gae D, Bailey SM, Taccioli GE, Blasco MA (2002) Functional interaction between DNA-PKcs and telomerase in telomere length maintenance. EMBO J 21:6275–6287
Shin DS, Chahwan C, Huffman JL, Tainer JA (2004) Structure and function of the double-strand break repair machinery. DNA Repair (Amst) 3:863–873
Schreiber V, Dantzer F, Ame JC, de Murcia G (2006) Poly(ADP-ribose): novel functions for an old molecule. Nat Rev Mol Cell Biol 7:517–528
Harper JW, Elledge SJ (2007) The DNA damage response: ten years after. Mol Cell 28:739–745
Meek DW, Anderson CW (2009) Posttranslational modification of p53: cooperative integrators of function. Cold Spring Harb Perspect Biol 1:a000950
Batchelor E, Loewer A, Lahav G (2009) The ups and downs of p53: understanding protein dynamics in single cells. Nat Rev Cancer 9:371–377
Sorensen CS, Hansen LT, Dziegielewski J, Syljuasen RG, Lundin C, Bartek J, Helleday T (2005) The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair. Nat Cell Biol 7:195–201
Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER III, Hurov KE, Luo J, Bakalarski CE, Zhao Z, Solimini N, Lerenthal Y et al (2007) ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316:1160–1166
Chipuk JE, Green DR (2003) p53′s believe it or not: lessons on transcription-independent death. J Clin Immunol 23:355–361
Fuster JJ, Sanz-Gonzalez SM, Moll UM, Andres V (2007) Classic and novel roles of p53: prospects for anticancer therapy. Trends Mol Med 13:192–199
Kern SE, Kinzler KW, Bruskin A, Jarosz D, Friedman P, Prives C, Vogelstein B (1991) Identification of p53 as a sequence-specific DNA-binding protein. Science 252:1708–1711
Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 253:49–53
Vogelstein B, Kinzler KW (2004) Cancer genes and the pathways they control. Nat Med 10:789–799
Vogelstein B, Lane D, Levine AJ (2000) Surfing the p53 network. Nature 408:307–310
Wei CL, Wu Q, Vega VB, Chiu KP, Ng P, Zhang T, Shahab A, Yong HC, Fu Y, Weng Z et al (2006) A global map of p53 transcription-factor binding sites in the human genome. Cell 124:207–219
McLure KG, Lee PW (1998) How p53 binds DNA as a tetramer. EMBO J 17:3342–3350
Aylon Y, Oren M (2007) Living with p53, dying of p53. Cell 130:597–600
Das S, Boswell SA, Aaronson SA, Lee SW (2008) P53 promoter selection: choosing between life and death. Cell Cycle 7:154–157
d’Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, von Zglinicki T, Saretzki G, Carter NP, Jackson SP (2003) A DNA damage checkpoint response in telomere-initiated senescence. Nature 426:194–198
von Zglinicki T, Saretzki G, Ladhoff J, d’Adda di Fagagna F, Jackson SP (2005) Human cell senescence as a DNA damage response. Mech Ageing Dev 126:111–117
Jack MT, Woo RA, Hirao A, Cheung A, Mak TW, Lee PW (2002) Chk2 is dispensable for p53-mediated G1 arrest but is required for a latent p53-mediated apoptotic response. Proc Natl Acad Sci U S A 99:9825–9829
Jack MT, Woo RA, Motoyama N, Takai H, Lee PW (2004) DNA-dependent protein kinase and checkpoint kinase 2 synergistically activate a latent population of p53 upon DNA damage. J Biol Chem 279:15269–15273
Lees-Miller SP, Sakaguchi K, Ullrich SJ, Appella E, Anderson CW (1992) Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53. Mol Cell Biol 12:5041–5049
Hill R, Leidal AM, Madureira PA, Gillis LD, Cochrane HK, Waisman DM, Chiu A, Lee PW (2008) Hypersensitivity to chromium-induced DNA damage correlates with constitutive deregulation of upstream p53 kinases in p21-/- HCT116 colon cancer cells. DNA Repair (Amst) 7:239–252
Hill R, Leidal AM, Madureira PA, Gillis LD, Waisman DM, Chiu A, Lee PW (2008) Chromium-mediated apoptosis: Involvement of DNA-dependent protein kinase (DNA-PK) and differential induction of p53 target genes. DNA Repair (Amst) 7:1484
Komiyama S, Taniguchi S, Matsumoto Y, Tsunoda E, Ohto T, Suzuki Y, Yin HL, Tomita M, Enomoto A, Morita A et al (2004) Potentiality of DNA-dependent protein kinase to phosphorylate Ser46 of human p53. Biochem Biophys Res Commun 323:816–822
Rathmell WK, Kaufmann WK, Hurt JC, Byrd LL, Chu G (1997) DNA-dependent protein kinase is not required for accumulation of p53 or cell cycle arrest after DNA damage. Cancer Res 57:68–74
Huang LC, Clarkin KC, Wahl GM (1996) p53-dependent cell cycle arrests are preserved in DNA-activated protein kinase-deficient mouse fibroblasts. Cancer Res 56:2940–2944
Gurley KE, Kemp CJ (1996) p53 induction, cell cycle checkpoints, and apoptosis in DNAPK-deficient scid mice. Carcinogenesis 17:2537–2542
Guidos CJ, Williams CJ, Grandal I, Knowles G, Huang MT, Danska JS (1996) V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors. Genes Dev 10:2038–2054
Kachnic LA, Wu B, Wunsch H, Mekeel KL, DeFrank JS, Tang W, Powell SN (1999) The ability of p53 to activate downstream genes p21(WAF1/cip1) and MDM2, and cell cycle arrest following DNA damage is delayed and attenuated in scid cells deficient in the DNA-dependent protein kinase. J Biol Chem 274:13111–13117
Woo RA, McLure KG, Lees-Miller SP, Rancourt DE, Lee PW (1998) DNA-dependent protein kinase acts upstream of p53 in response to DNA damage. Nature 394:700–704
Jimenez GS, Bryntesson F, Torres-Arzayus MI, Priestley A, Beeche M, Saito S, Sakaguchi K, Appella E, Jeggo PA, Taccioli GE et al (1999) DNA-dependent protein kinase is not required for the p53-dependent response to DNA damage. Nature 400:81–83
Bharti A, Kraeft SK, Gounder M, Pandey P, Jin S, Yuan ZM, Lees-Miller SP, Weichselbaum R, Weaver D, Chen LB et al (1998) Inactivation of DNA-dependent protein kinase by protein kinase Cdelta: implications for apoptosis. Mol Cell Biol 18:6719–6728
Wang S, Guo M, Ouyang H, Li X, Cordon-Cardo C, Kurimasa A, Chen DJ, Fuks Z, Ling CC, Li GC (2000) The catalytic subunit of DNA-dependent protein kinase selectively regulates p53-dependent apoptosis but not cell-cycle arrest. Proc Natl Acad Sci U S A 97:1584–1588
Woo RA, Jack MT, Xu Y, Burma S, Chen DJ, Lee PW (2002) DNA damage-induced apoptosis requires the DNA-dependent protein kinase, and is mediated by the latent population of p53. EMBO J 21:3000–3008
Achanta G, Pelicano H, Feng L, Plunkett W, Huang P (2001) Interaction of p53 and DNA-PK in response to nucleoside analogues: potential role as a sensor complex for DNA damage. Cancer Res 61:8723–8729
Hill R, Madureira PA, Waisman DM, Lee PW (2011) DNA-PKCS binding to p53 on the p21WAF1/CIP1 promoter blocks transcription resulting in cell death. Oncotarget 2:1094–1108
Bekker-Jensen S, Lukas C, Kitagawa R, Melander F, Kastan MB, Bartek J, Lukas J (2006) Spatial organization of the mammalian genome surveillance machinery in response to DNA strand breaks. J Cell Biol 173:195–206
Rinaldo C, Prodosmo A, Mancini F, Iacovelli S, Sacchi A, Moretti F, Soddu S (2007) MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosis. Mol Cell 25:739–750
Mukherjee B, Kessinger C, Kobayashi J, Chen BP, Chen DJ, Chatterjee A, Burma S (2006) DNA-PK phosphorylates histone H2AX during apoptotic DNA fragmentation in mammalian cells. DNA Repair (Amst) 5:575–590
Sluss HK, Davis RJ (2006) H2AX is a target of the JNK signaling pathway that is required for apoptotic DNA fragmentation. Mol Cell 23:152–153
Skalka AM (2013) HIV: integration triggers death. Nature 498:305–306
Cooper A, Garcia M, Petrovas C, Yamamoto T, Koup RA, Nabel GJ (2013) HIV-1 causes CD4 cell death through DNA-dependent protein kinase during viral integration. Nature 498:376–379
Yang CR, Leskov K, Hosley-Eberlein K, Criswell T, Pink JJ, Kinsella TJ, Boothman DA (2000) Nuclear clusterin/XIP8, an x-ray-induced Ku70-binding protein that signals cell death. Proc Natl Acad Sci U S A 97:5907–5912
Liu J, Naegele JR, Lin SL (2009) The DNA-PK catalytic subunit regulates Bax-mediated excitotoxic cell death by Ku70 phosphorylation. Brain Res 1296:164
Espejel S, Franco S, Rodriguez-Perales S, Bouffler SD, Cigudosa JC, Blasco MA (2002) Mammalian Ku86 mediates chromosomal fusions and apoptosis caused by critically short telomeres. EMBO J 21:2207–2219
Lee HW, Blasco MA, Gottlieb GJ, Horner JW, Greider CW, DePinho RA (1998) Essential role of mouse telomerase in highly proliferative organs. Nature 392:569–574
Lim S, Kaldis P (2013) Cdks, cyclins and CKIs: roles beyond cell cycle regulation. Development 140:3079–3093
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Hill, R. (2015). Apoptosis. In: de Mello, R., Tavares, Á., Mountzios, G. (eds) International Manual of Oncology Practice. Springer, Cham. https://doi.org/10.1007/978-3-319-21683-6_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-21683-6_3
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-21682-9
Online ISBN: 978-3-319-21683-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)